VEGFR2/CD309 anticorps (AA 20-762) (Biotin)
Aperçu rapide pour VEGFR2/CD309 anticorps (AA 20-762) (Biotin) (ABIN6757558)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 20-762
-
Specificité
- Reacts specifically with human FLK-1/VEGFR-2/KDR. No cross-reactivity with VGFR-1/FLT-1 or FLT-4.
-
Purification
- Purified
-
Immunogène
- Recombinant human Flk-1.
-
Isotype
- IgG
-
-
anti-VEGF Receptor 2 (VEGFR2) (AA 20-244) antibody
VEGFR2 Reactivité: Souris, Rat WB, IHC, FACS, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-242) antibodyVEGFR2 Reactivité: Humain WB, IHC, FACS, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356), (C-Term) antibodyVEGFR2 Reactivité: Humain WB, FACS, IF, IHC (p) Hôte: Lapin Polyclonal RB01536 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr951) antibodyVEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1326-1356) antibodyVEGFR2 Reactivité: Humain WB, IHC, ELISA, FACS, IF Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 101-200) antibodyVEGFR2 Reactivité: Humain, Souris, Rat, Lapin ELISA, FACS, IHC (p), IF (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (pTyr1214) antibodyVEGFR2 Reactivité: Humain, Souris, Rat WB, IHC, ELISA, IF, ICC Hôte: Lapin Polyclonal unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 1225-1356) antibodyVEGFR2 Reactivité: Humain ELISA, FACS Hôte: Souris Monoclonal 1A9A3 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 20-764) antibodyVEGFR2 Reactivité: Humain ELISA, FACS, ICC Hôte: Souris Monoclonal 4B4 unconjugated
anti-VEGF Receptor 2 (VEGFR2) (AA 454-469), (Middle Region) antibodyVEGFR2 Reactivité: Humain WB, IHC, ICC Hôte: Lapin Polyclonal unconjugated
-
-
Indications d'application
-
Approved: ELISA (1:5000 - 1:50000)
Usage: Suitable for use in ELISA. ELISA: 1:10,000-1:100,000, using 50-100 ng of control peptide/well. The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Reconstitution
- 100 μL sterile ddH20
-
Concentration
- Lot specific
-
Buffer
- 100 mM Tris, pH 7.5, 0.2 % BSA, 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing cycles.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Can be stored at 4°C. For long term storage, aliquot and store at -20°C. Avoid freeze-thaw cycles.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- KDR / VEGFR2
-
Sujet
-
Name/Gene ID: KDR
Subfamily: VEGF Receptor
Family: Protein Kinase
Synonyms: KDR, CD309, Fetal liver kinase 1, Fetal liver kinase-1, FLK-1, FLK1, Kinase insert domain receptor, Quek1, VEGFR, VEGFR2, Soluble VEGFR2, VEGF receptor 2, VEGFR-2, CD309 antigen, VEGF-R2 -
ID gène
- 3791
-
UniProt
- P35968
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-
